Spruce Biosciences
-$0.03 (-2.27%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRB and other ETFs, options, and stocks.
About SPRB
Spruce Biosciences, Inc operates as a late-stage biopharmaceutical company, which focuses on the development of novel therapies for rare diseases affecting the endocrine system. The firm is initially developing its wholly-owned product candidate, tildacerfont, as the non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia.
CEO
Javier Szwarcberg
Employees
15
Headquarters
Daly City, California
Founded
2014
SPRB Key Statistics
Market cap
30.99M
Price-Earnings ratio
—
Dividend yield
—
Average volume
105.12K
High today
$1.46
Low today
$1.25
Open price
$1.46
Volume
119.48K
52 Week high
$15.08
52 Week low
$1.25
Analyst ratings
71%
of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%
SPRB Earnings
-$12.35
-$8.23
-$4.12
-$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.46 per share
Actual
-$0.50 per share